🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A prospective, parallel-group, double-blind, randomized placebo-controlled ...
Status
Unknown
Location
University of Puerto Rico, Medical Sciences Campus
Start Date
2020-05-15
Trial ID
NCT04380025
Treatments Being Tested
This purpose of this study is to access the efficacy, tolerability and safe...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-01
Trial ID
NCT00846989
Treatments Being Tested
This is a multicenter, double-masked study to evaluate the use of Topical O...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07412496
The purpose of this study is to evaluate the effect of Azasite on patients ...
Status
Withdrawn
Location
Philadelphia Eye Associates
Start Date
2013-03
Trial ID
NCT01797107
Treatments Being Tested
Cross-linking of the cornea increases the mechanical and biochemical stabil...
Status
Unknown
Location
Clementino Fraga Filho University Hospital
Start Date
2007-02
Trial ID
NCT00642044
Treatments Being Tested
To assess the safety and efficacy of PACK-CXL (photoactivated chromophore f...
Status
Completed
Location
University of Geneva
Start Date
2016-03
Trial ID
NCT02717871
Treatments Being Tested
The purpose of this Phase 1b study is to evaluate the safety, tolerability,...
Status
Completed
Location
PPD
Start Date
2019-05-02
Trial ID
NCT04284514
Treatments Being Tested
This study will identify the optimum concentrations of AGN-199201 and AGN-1...
Status
Completed
Location
Sall Research Medical Center
Start Date
2016-04-29
Trial ID
NCT02595528
This is a Phase II/III vehicle controlled, double masked, single center stu...
Status
Terminated
Location
University of Michigan
Start Date
2012-10
Trial ID
NCT01601483
Treatments Being Tested
The objective of this study is to compare the safety and efficacy of 0.25% ...
Status
Completed
Location
Xiamen Eye Center of Xiamen University
Start Date
2021-02-25
Trial ID
NCT04633213
Treatments Being Tested